IN2014DN11097A - - Google Patents

Download PDF

Info

Publication number
IN2014DN11097A
IN2014DN11097A IN11097DEN2014A IN2014DN11097A IN 2014DN11097 A IN2014DN11097 A IN 2014DN11097A IN 11097DEN2014 A IN11097DEN2014 A IN 11097DEN2014A IN 2014DN11097 A IN2014DN11097 A IN 2014DN11097A
Authority
IN
India
Prior art keywords
particles
titanium
micrometer
cavities
exhibit
Prior art date
Application number
Inventor
Lars Magnus Bjursten
Sven Erik Nilsson
Original Assignee
Migrata U K Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Migrata U K Ltd filed Critical Migrata U K Ltd
Publication of IN2014DN11097A publication Critical patent/IN2014DN11097A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414—Particles, beads, capsules or spheres
    • A61K49/0419—Microparticles, microbeads, microcapsules, microspheres, i.e. having a size or diameter higher or equal to 1 micrometer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414—Particles, beads, capsules or spheres

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The present invention describes particles of titanium titanium alloy at least one type of titanium oxide or a combination thereof wherein at least a substantial amount of the particles are of micrometer millimeter size and are non spherical for use as an X ray contrast agent. The irregular shapes and/or internal pores and cavities of said particles lead to a prolonged retention time in the gastrointestinal tract leading to a longer time period available for X ray examination. Further the particles are not only chemically inert they also exhibit an anti inflammatory and anti bacterial effect on the surrounding tissue.
IN11097DEN2014 2012-06-04 2013-05-29 IN2014DN11097A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261655093P 2012-06-04 2012-06-04
SE1250582 2012-06-04
PCT/SE2013/050620 WO2013184061A1 (en) 2012-06-04 2013-05-29 Medical use of particles of titanium and/or titanium oxide

Publications (1)

Publication Number Publication Date
IN2014DN11097A true IN2014DN11097A (en) 2015-09-25

Family

ID=49712337

Family Applications (1)

Application Number Title Priority Date Filing Date
IN11097DEN2014 IN2014DN11097A (en) 2012-06-04 2013-05-29

Country Status (5)

Country Link
US (1) US20150139913A1 (en)
EP (1) EP2854868A4 (en)
CN (1) CN104736184A (en)
IN (1) IN2014DN11097A (en)
WO (1) WO2013184061A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11033640B2 (en) 2013-03-15 2021-06-15 The Regents Of The University Of California Enteric CT contrast material based on low-z atoms
US20160193366A1 (en) 2013-08-16 2016-07-07 The Regents Of The University Of California Silicone-based enteric ct contrast material
CN113456839B (en) * 2021-07-05 2022-06-21 浙江大学 Dipole resonance enhanced double-negative acoustic metamaterial and application thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4020152A (en) * 1973-12-18 1977-04-26 Thann & Mulhouse Barium titanate and barium zirconate in radiological contrast products
EP0253554A3 (en) * 1986-07-15 1988-07-20 Pfizer Inc. Controlled release drug-containing fibers
GB9204388D0 (en) * 1992-02-29 1992-04-15 Tioxide Specialties Ltd Water-in-oil emulsions
US5593657A (en) * 1995-02-09 1997-01-14 Nanosystems L.L.C. Barium salt formulations stabilized by non-ionic and anionic stabilizers
US6024569A (en) * 1998-11-06 2000-02-15 Aytec Japan Corporation Root canal filling point
SE515227C2 (en) * 1999-04-28 2001-07-02 Bruce Medical Ab Body for providing and growing bone and / or connective tissue and methods for making the body
DE10018405B4 (en) * 2000-04-13 2004-07-08 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Spherical oxidic particles and their use
US6394965B1 (en) * 2000-08-15 2002-05-28 Carbon Medical Technologies, Inc. Tissue marking using biocompatible microparticles
EP1494730B1 (en) * 2002-03-22 2012-01-18 Kuros Biosurgery AG Composition for hard tissue augmentation
US8012454B2 (en) * 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
JP4474878B2 (en) * 2003-09-17 2010-06-09 株式会社Ｉｈｉ X-ray contrast medium and method for producing X-ray contrast medium
EP1828056A1 (en) * 2004-11-02 2007-09-05 Nanogate AG Synthesis of titanium dioxide nanoparticles
SE531318C2 (en) * 2007-02-22 2009-02-24 Tigran Technologies Ab Publ Injectable suspension comprising microstructure titanium titanium, titanium alloy or titanium oxide particles
JP2008297289A (en) * 2007-06-04 2008-12-11 Canon Inc Contrast agent and method for producing the same
EP2344569B1 (en) * 2008-09-30 2019-03-13 SABIC Global Technologies B.V. X-ray and/or metal detectable articles and method of making the same
GB0921596D0 (en) * 2009-12-09 2010-01-27 Isis Innovation Particles for the treatment of cancer in combination with radiotherapy
WO2011084625A1 (en) * 2009-12-16 2011-07-14 Georgia Tech Research Corporation Systems and methods for x-ray flourescence computed tomography imaging with nanoparticles

Also Published As

Publication number Publication date
WO2013184061A1 (en) 2013-12-12
EP2854868A4 (en) 2016-01-20
CN104736184A (en) 2015-06-24
US20150139913A1 (en) 2015-05-21
EP2854868A1 (en) 2015-04-08

Similar Documents

Publication Publication Date Title
EP3686184A3 (en) Ionizable compounds and compositions and uses thereof
IL255113A0 (en) Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
CA2865972C (en) Inhalable dry powders
WO2012121528A3 (en) Magnetic nanocomposite specific for thyroid cancer and use thereof
EP2833721A4 (en) PHARMACEUTICAL COMPOSITIONS RELEASING NITRIC OXIDE
IL223889B (en) Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects
MX2019000225A (en) Compositions and methods for treatment of autoimmune and other disease.
EP3861982A3 (en) Intracameral implant for treatment of an ocular condition
IL222548A (en) Hydroxamic acid derivatives and pharmaceutical compositions and antimicrobial agents comprising the same
WO2012138379A3 (en) Multifunctional chelator-free radioactive nanoparticles for imaging and therapy
BR112012004967A2 (en) oral dosage form comprising at least one biologically active agent, formulation aids and magnetizable particles
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
EP3052191A4 (en) Directed differentiation of astrocytes from human pluripotent stem cells for use in drug screening and the treatment of amyotrophic lateral sclerosis (als)
SG11201510021TA (en) Compositions and methods for use in medical diagnosis
PT2523674E (en) Compositions comprising andrographis paniculata extracts combined with ginkgo biloba extracts complexed with phospholipids, and their use
JP2012528941A5 (en)
IN2014DN11097A (en)
EP4233915A3 (en) Modified release formulations of viloxazine
WO2015073177A8 (en) Vaginal inserted estradiol pharmaceutical compositons and methods
IL238937A0 (en) Fibrinolytic compositions comprising bromelain and nattokinase for the prevention and treatment of phlebothrombotic states
EP4356967A3 (en) Compounds for use as imaging agents
WO2015054208A8 (en) Injectable compositions
EP2993206A4 (en) COMPOSITION CONTAINING TITANIUM OXIDE, POLYMER COMPOSITION, AND MOLDED BODY
EP2880103A4 (en) OXIDE COATED METAL PIGMENTS AND FILMOGENIC COMPOSITIONS
HUE042638T2 (en) A pharmaceutical composition comprising a solid nanoparticle and at least an antigen for the treatment against an intracellular pathogenic agent